Corbus Pharmaceuticals Holdings Cash from Financing (TTM) Analysis

Corbus Pharmaceuticals Holdings Inc (CRBP)

37.84 +0.14 (+0.37%) USD | NASDAQ | Apr 23, 16:00

37.85 +0.01 (+0.03%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	-2.820M
September 30, 2023	-0.6815M
June 30, 2023	0.0283M
March 31, 2023	-0.3195M
December 31, 2022	-0.5336M
September 30, 2022	0.00
June 30, 2022	0.008M
March 31, 2022	0.0825M
December 31, 2021	60.82M
September 30, 2021	81.79M
June 30, 2021	128.62M
March 31, 2021	172.35M
December 31, 2020	154.87M
September 30, 2020	133.89M
June 30, 2020	87.14M
March 31, 2020	43.47M
December 31, 2019	38.46M
September 30, 2019	38.11M
June 30, 2019	38.07M

Date	Value
March 31, 2019	38.22M
December 31, 2018	11.42M
September 30, 2018	46.61M
June 30, 2018	46.62M
March 31, 2018	46.53M
December 31, 2017	76.01M
September 30, 2017	42.09M
June 30, 2017	42.30M
March 31, 2017	57.42M
December 31, 2016	16.74M
September 30, 2016	15.23M
June 30, 2016	21.50M
March 31, 2016	10.78M
December 31, 2015	10.84M
September 30, 2015	10.72M
June 30, 2015	3.972M
March 31, 2015	8.376M
December 31, 2014	8.385M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-2.820M

Minimum

Dec 2023

172.35M

Maximum

Mar 2021

51.23M

Average

38.11M

Median

Sep 2019

Cash from Financing (TTM) Benchmarks